1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T76871 | Navicixizumab | ||
Navicixizumab (OMP-305B83) is a bispecific anti- VEGF and anti- DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel for cancer research. Navicixizumab can be used in the research of ovarian, primary peri... |